What is Lynch syndrome?
Lynch syndrome is an inherited condition that increases the risk of several cancers, especially colorectal cancer.
What is a cancer-prevention vaccine?
Unlike vaccines that prevent infections (such as flu or COVID-19), these vaccines are designed to train the immune system to recognise and destroy abnormal cells before they become cancer.
What are researchers working on?
Scientists have found that many Lynch syndrome–related precancerous cells share common genetic changes (called neoantigens). This means it may be possible to create a vaccine that helps the immune system target these cells early.
Key updates
- Researchers have identified promising vaccine targets in Lynch syndrome–associated precancers.
- Several early-stage vaccine studies and clinical trials are underway.
- The goal is to reduce the risk of cancer developing, rather than treating cancer after it appears.
- These vaccines are still experimental and are not yet part of standard care.
What does this mean for people with Lynch syndrome?
- The research is encouraging and could lead to new ways of preventing cancer in the future.
- Regular screening (such as colonoscopies) remains the most important proven method of cancer prevention right now.
- Some people may be eligible to participate in clinical trials studying preventive vaccines.
Bottom line
Researchers are making progress toward a vaccine that could help prevent cancer in people with Lynch syndrome. The science is promising, but these vaccines are still being tested and are not yet available for routine use. Regular surveillance and current prevention strategies remain essential.
https://www.cgaigc.com/post/updates-in-vaccine-chemoprevention-in-lynch-syndrome
Lynch Syndrome Ireland 